Ganesh Benzoplast is no longer primarily a liquid storage terminal compounder. On 7 Oct 2026 it announced the sale of its JNPA, Goa and Cochin tank farm businesses and the JNPA-linked Daund rail business for INR1,154 crore, retaining only a small, insignificant Kandla terminal shareholding. The transaction transforms the investment case into a special situation: a cash-backed chemical and EPC business, a defined capital-return plan, and a new set of operating targets. The key debate is not the old JNPT lease reset or the 1 lakh kL LST expansion; those assets are being sold. It is whether the chemical and EPC businesses can earn a higher return on the proceeds than the LST business would have.
The deal economics are clear. Management expects INR500 crore before January 2027, INR300 crore before March 2027 and the balance INR354 crore over 12-18 months, subject to port and shareholder approvals. Of the first tranche, INR190-200 crore is for taxes and closing bank limits, about INR200 crore for buyback and special dividend, and about INR100 crore for chemical and EPC expansion. The buyback is intended to be open to public shareholders only; promoters will not participate. This is a credible capital-return plan, but it is not yet declared. The buyback announcement depends on definite visibility of the money, and the board may change the amount with capital needs. The first test is therefore transaction completion, not industrial execution.
The remaining business has two engines. Chemicals made about INR60 crore of revenue and INR6 crore of profit in the June 2026 quarter; management expects chemical revenue above INR200 crore and PAT above INR20 crore this year. REACH certification for benzoic acid and sodium benzoate in the UK and Europe has brought orders above 600 tonnes, expected to reach about 2,000 tonnes a year. GBL is doubling capacity at one of its two plants, each about 1,000 tonnes a month, with completion expected in July 2027. It also targets chemical profitability of INR60-70 crore in four to five years, from the INR18 crore cited in the Q2 FY27 call, helped by new agro and derivative products that could double turnover and profitability. The new products are not yet approved or costed; they depend on technology licences and customer buyback arrangements.
EPC is the second engine. Management has shifted it from strategic support for LST to an independent growth division. A KKR order of almost INR300 crore lifts the current-year EPC book to about INR500 crore. Management guides about INR250 crore of EPC revenue next year against INR50-60 crore this year, an order book of INR500-600 crore next year, INR2,500-3,000 crore in four to five years, and EPC PAT of about INR150 crore by FY2030. The target assumes winning 5% of INR70,000 crore of petroleum-related EPC works; management says it cannot commit to these numbers. EPC margins have historically been 5-10%, so the PAT target requires scale, not just order intake. Working capital and bank guarantees are the constraints.
The earnings path is therefore back-end loaded. In the near term, the June 2026 chemical run-rate and the first divestment tranche dominate. In FY28, the one-plant chemical doubling and the first full year of EPC revenue should begin to show. The larger chemical and EPC targets are four-to-five-year aspirations. The JNPT LST profits are expected to stop from the March 2027 quarter, with Cochin and Goa dropping out gradually over the following year. That creates an earnings hole before the new chemical and EPC capacity ramps. The balance sheet should be strong after the sale, but the buyback and dividend will reduce cash, and management still needs bank lines for guarantees.
Capital allocation is the central judgment. The company is selling a steady, high-margin port business and using the proceeds for buyback, dividend, chemical expansion and EPC growth. That can create value if the chemical and EPC returns exceed the LST cash flows sold. It destroys value if the proceeds are returned at a low valuation or spent on projects that do not earn a return. Management has not disclosed project-level IRRs or the split of the INR150 crore stage-one chemical and EPC capex. The INR100 crore first-tranche allocation and the INR150 crore stage-one cap are separate disclosures for the same two areas, not additive project budgets. Investors should watch the buyback price and size, the chemical plant commissioning, REACH order conversion, and EPC order intake.
Management delivery is mixed. The chemical turnaround and EPC order wins are tangible. The prior JNPT expansion, land-use and dividend timelines were not delivered as framed; the sale is a strategic reset rather than a completion of those promises. The company has been consistent on debt avoidance and on using internal accruals. The new promises are the divestment tranches, the buyback/special dividend, the July 2027 chemical completion, and the EPC targets. Each is dated and testable.
Falsifiers: port or shareholder approvals delay the first tranche beyond January 2027; the buyback is not announced or is materially smaller than INR200 crore; the chemical plant doubling slips beyond July 2027; REACH orders fail to scale toward 2,000 tonnes a year; new agro products do not secure licences or customer buyback; EPC order intake falls short of the 5% share assumption; or crude-linked raw material volatility compresses chemical margins. On the upside, the sale completes, the buyback is announced, chemical profitability reaches the INR60-70 crore target, and EPC earns about INR150 crore PAT by FY2030. The stock is a special situation with a credible cash return and a smaller, higher-risk industrial business, not the old LST compounder.
companyname: Ganesh Benzoplast Limited ticker: GANESHBE sector: Specialty Chemicals Manufacturing & EPC (LST divestment announced) Ganesh Benzoplast Limited (GBL) manufactures specialty chemicals at its Tarapur plant in Maharashtra and provides engineering, procurement and construction (EPC) services for tank farms and pipelines through GBL Infra. It has agreed to divest its liquid storage terminals at JNPA, Goa and Cochin, together with the JNPA-linked rail business connecting Daund, for INR1,...
Read the full report →capex, margin expansion
Management expects INR500 crore of divestment proceeds before January 2027, INR300 crore before March 2027 and INR354 crore over 12-18 months, subject to port and shareholder approvals. It plans about INR200 crore of the first tranche for buyback/special dividend and INR100 crore for chemical and EPC, with stage-one chemical and EPC capex capped at INR150 crore. It guides one chemical plant doubling by July 2027, FY27 chemical revenue above INR200 crore and chemical PAT above INR20 crore, chemical profitability of INR60-70 crore in four to five years, EPC revenue around INR250 crore next year, EPC order book of INR500-600 crore next year and INR2,500-3,000 crore in four to five years, and EPC PAT of about INR150 crore by FY2030.
Guidance no_dataGet valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Ganesh Benzoplast Limited and 4,900+ companies.
5-day free pass. No card required.